CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

oxygen treatmentWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug653 Prone Wiki 1.00
drug883 Usual Care Wiki 0.50

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Sequential Oxygen Therapy Strategy for Patients With COVID-19

All patients with COVID-19 were divided into three groups according to their illness: mild patient who receive conventional oxygen therapy, severe patients who receive nasal high flow oxygen inhalation or non-invasive positive pressure ventilation，all the oxygen therapy will be used as part of the standard of care. Each group will enroll 10 patients, the treatment of all patients will be continuously optimized during observation, and the incidence of respiratory failure, intubation rate, 28 day mortality rate, ICU hospitalization days, etc will be recorded and analyzed so to optimize the treatment time window of sequential oxygen therapy

NCT04312100 Coronavirus Disease-2019 Other: oxygen treatment
MeSH:Coronavirus Infections

Primary Outcomes

Description: Incidence of respiratory failure at day 28 after enrollment

Measure: Incidence of respiratory failure

Time: 28 day

Secondary Outcomes

Description: mortality rate at day 28 after enrollment

Measure: 28 day mortality rate

Time: 28 day

No related HPO nodes (Using clinical trials)